Lehr Martin A. 4
4 · Context Therapeutics Inc. · Filed Feb 25, 2022
Insider Transaction Report
Form 4
Lehr Martin A.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-25+254,300→ 254,300 totalExercise: $1.79Exp: 2032-02-24→ Common Stock (254,300 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 25, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer.